US Patent No. 9,347,100

Rare cell analysis using sample splitting and DNA tags
May 25, 2016

Verinata Health (Illumina), the General Hospital, and GPB Scientific have been awarded US Patent No. 9,347,100, "Rare cell analysis using sample splitting and DNA tags."

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.